Header Logo

Connection

Kathleen Moore to Placebo Effect

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Placebo Effect.
Kathleen Moore
Connection Strength
0.046
Placebo Effect
  1. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database. Lancet Haematol. 2021 Feb; 8(2):e122-e134.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.